Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Mercaptoacyl amino acid inhibitors of atriopeptidase. 1. Structure-activity relationship studies of methionine and S-alkylcysteine derivatives.

Neustadt BR, Smith EM, Nechuta TL, Bronnenkant AA, Haslanger MF, Watkins RW, Foster CJ, Sybertz EJ.

J Med Chem. 1994 Jul 22;37(15):2461-76.

PMID:
8057292
3.

7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza omega-chain analogues.

Nakane M, Reid JA, Han WC, Das J, Truc VC, Haslanger MF, Garber D, Harris DN, Hedberg A, Ogletree ML, et al.

J Med Chem. 1990 Sep;33(9):2465-76.

PMID:
2391688
4.

9,11-epoxy-9-homoprosta-5-enoic acid analogues as thromboxane A2 receptor antagonists.

Das J, Hall SE, Nakane M, Haslanger MF, Reid JA, Garber D, Truc VC, Harris DN, Hedberg A, Ogletree ML.

J Med Chem. 1990 Jun;33(6):1741-8.

PMID:
2140414
5.

Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.

Sybertz EJ, Chiu PJ, Vemulapalli S, Watkins R, Haslanger MF.

Hypertension. 1990 Feb;15(2):152-61.

PMID:
2154404
6.

Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope.

Swenson TL, Hesler CB, Brown ML, Quinet E, Trotta PP, Haslanger MF, Gaeta FC, Marcel YL, Milne RW, Tall AR.

J Biol Chem. 1989 Aug 25;264(24):14318-26.

7.

SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.

Sybertz EJ, Chiu PJ, Vemulapalli S, Pitts B, Foster CJ, Watkins RW, Barnett A, Haslanger MF.

J Pharmacol Exp Ther. 1989 Aug;250(2):624-31.

PMID:
2547941
8.

Carboxyalkyl dipeptides with atrial natriuretic factor potentiating and antihypertensive activity.

Haslanger MF, Sybertz EJ, Neustadt BR, Smith EM, Nechuta TL, Berger J.

J Med Chem. 1989 Apr;32(4):737-9. No abstract available.

PMID:
2522989
9.

9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenase.

Hall SE, Han WC, Haslanger MF, Harris DN, Ogletree ML.

J Med Chem. 1986 Nov;29(11):2335-47.

PMID:
3097316
10.

Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.

Ogletree ML, Harris DN, Greenberg R, Haslanger MF, Nakane M.

J Pharmacol Exp Ther. 1985 Aug;234(2):435-41.

PMID:
3926986
11.

Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.

Nakane M, Reid JA, Haslanger MF, Garber DP, Harris DN, Ogletree ML, Greenberg R.

Adv Prostaglandin Thromboxane Leukot Res. 1985;15:291-3. No abstract available.

PMID:
3004140
12.

Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle.

Harris DN, Greenberg R, Phillips MB, Michel IM, Goldenberg HJ, Haslanger MF, Steinbacher TE.

Eur J Pharmacol. 1984 Aug 3;103(1-2):9-18.

PMID:
6090180
13.

Thromboxane receptor antagonist properties of SQ 27,427 in the anesthetized guinea pig.

Greenberg R, Steinbacher TE, Harris DN, Haslanger MF.

Eur J Pharmacol. 1984 Aug 3;103(1-2):19-24.

PMID:
6090175
14.

Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.

Haslanger MF, Sprague PW, Snitman D, Vu T, Harris DN, Greenberg R, Powell J.

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:293-7. No abstract available.

PMID:
6221540
15.

Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.

Harris DN, Phillips MB, Michel IM, Goldenberg HJ, Haslanger MF, Antonaccio MJ, Fried J.

Thromb Res. 1981 Aug 15-Sep 1;23(4-5):387-99. No abstract available.

PMID:
6275567

Supplemental Content

Loading ...
Support Center